Selected research
Industry Research
Chinese Medicine Injection Industry Research Report 2026
Market perspective
The global Chinese Medicine Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Chinese Medicine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Chinese Medicine Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Chinese Medicine Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Chinese Medicine Injection include ZBD Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Changbaishan Pharmaceutical, Wuzhou Pharmaceutical, Yusheng Pharmaceutical, Chase Sun Pharmaceutical, Green Valley Pharma, Livzon and Qingfeng Pharmaceutical Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Chinese Medicine Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chinese Medicine Injection Market by Company
ZBD Pharmaceutical
Zhejiang Kanglaite Pharmaceutical
Changbaishan Pharmaceutical
Wuzhou Pharmaceutical
Yusheng Pharmaceutical
Chase Sun Pharmaceutical
Green Valley Pharma
Livzon
Qingfeng Pharmaceutical Group
Gerun Pharmaceutical
Fusen Pharmaceutical
Shineway Pharmaceutical
Harbin Pharmaceutical Group
Buchang Pharmaceutical
Chinese Medicine Injection Segment by Type
Anti-tumor Drugs
Cerebrovascular Disease Medication
Detoxification
Cardiovascular Disease Medication
other
Chinese Medicine Injection Segment by Application
Adult
Children
Chinese Medicine Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chinese Medicine Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chinese Medicine Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chinese Medicine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-tumor Drugs
- Cerebrovascular Disease Medication
- Detoxification
- Cardiovascular Disease Medication
- other
Applications
- Adult
- Children
Companies covered
- ZBD Pharmaceutical
- Zhejiang Kanglaite Pharmaceutical
- Changbaishan Pharmaceutical
- Wuzhou Pharmaceutical
- Yusheng Pharmaceutical
- Chase Sun Pharmaceutical
- Green Valley Pharma
- Livzon
- Qingfeng Pharmaceutical Group
- Gerun Pharmaceutical
- Fusen Pharmaceutical
- Shineway Pharmaceutical
- Harbin Pharmaceutical Group
- Buchang Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Chinese Medicine Injection Market Size (2021-2032)
- 2.2.2 Global Chinese Medicine Injection Sales (2021-2032)
- 2.2.3 Global Chinese Medicine Injection Market Average Price (2021-2032)
- 2.3 Chinese Medicine Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Anti-tumor Drugs
- 2.3.3 Cerebrovascular Disease Medication
- 2.3.4 Detoxification
- 2.3.5 Cardiovascular Disease Medication
- 2.3.6 other
- 2.4 Chinese Medicine Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult
- 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Chinese Medicine Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Chinese Medicine Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Chinese Medicine Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Chinese Medicine Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Chinese Medicine Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Chinese Medicine Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Chinese Medicine Injection, Product Type & Application
- 3.8 Global Manufacturers of Chinese Medicine Injection, Established Date
- 3.9 Global Chinese Medicine Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ZBD Pharmaceutical
- 4.1.1 ZBD Pharmaceutical Company Information
- 4.1.2 ZBD Pharmaceutical Business Overview
- 4.1.3 ZBD Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ZBD Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.1.5 ZBD Pharmaceutical Recent Developments
- 4.2 Zhejiang Kanglaite Pharmaceutical
- 4.2.1 Zhejiang Kanglaite Pharmaceutical Company Information
- 4.2.2 Zhejiang Kanglaite Pharmaceutical Business Overview
- 4.2.3 Zhejiang Kanglaite Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zhejiang Kanglaite Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.2.5 Zhejiang Kanglaite Pharmaceutical Recent Developments
- 4.3 Changbaishan Pharmaceutical
- 4.3.1 Changbaishan Pharmaceutical Company Information
- 4.3.2 Changbaishan Pharmaceutical Business Overview
- 4.3.3 Changbaishan Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Changbaishan Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.3.5 Changbaishan Pharmaceutical Recent Developments
- 4.4 Wuzhou Pharmaceutical
- 4.4.1 Wuzhou Pharmaceutical Company Information
- 4.4.2 Wuzhou Pharmaceutical Business Overview
- 4.4.3 Wuzhou Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wuzhou Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.4.5 Wuzhou Pharmaceutical Recent Developments
- 4.5 Yusheng Pharmaceutical
- 4.5.1 Yusheng Pharmaceutical Company Information
- 4.5.2 Yusheng Pharmaceutical Business Overview
- 4.5.3 Yusheng Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Yusheng Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.5.5 Yusheng Pharmaceutical Recent Developments
- 4.6 Chase Sun Pharmaceutical
- 4.6.1 Chase Sun Pharmaceutical Company Information
- 4.6.2 Chase Sun Pharmaceutical Business Overview
- 4.6.3 Chase Sun Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chase Sun Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.6.5 Chase Sun Pharmaceutical Recent Developments
- 4.7 Green Valley Pharma
- 4.7.1 Green Valley Pharma Company Information
- 4.7.2 Green Valley Pharma Business Overview
- 4.7.3 Green Valley Pharma Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Green Valley Pharma Chinese Medicine Injection Product Portfolio
- 4.7.5 Green Valley Pharma Recent Developments
- 4.8 Livzon
- 4.8.1 Livzon Company Information
- 4.8.2 Livzon Business Overview
- 4.8.3 Livzon Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Livzon Chinese Medicine Injection Product Portfolio
- 4.8.5 Livzon Recent Developments
- 4.9 Qingfeng Pharmaceutical Group
- 4.9.1 Qingfeng Pharmaceutical Group Company Information
- 4.9.2 Qingfeng Pharmaceutical Group Business Overview
- 4.9.3 Qingfeng Pharmaceutical Group Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Qingfeng Pharmaceutical Group Chinese Medicine Injection Product Portfolio
- 4.9.5 Qingfeng Pharmaceutical Group Recent Developments
- 4.10 Gerun Pharmaceutical
- 4.10.1 Gerun Pharmaceutical Company Information
- 4.10.2 Gerun Pharmaceutical Business Overview
- 4.10.3 Gerun Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Gerun Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.10.5 Gerun Pharmaceutical Recent Developments
- 4.11 Fusen Pharmaceutical
- 4.11.1 Fusen Pharmaceutical Company Information
- 4.11.2 Fusen Pharmaceutical Business Overview
- 4.11.3 Fusen Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Fusen Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.11.5 Fusen Pharmaceutical Recent Developments
- 4.12 Shineway Pharmaceutical
- 4.12.1 Shineway Pharmaceutical Company Information
- 4.12.2 Shineway Pharmaceutical Business Overview
- 4.12.3 Shineway Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shineway Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.12.5 Shineway Pharmaceutical Recent Developments
- 4.13 Harbin Pharmaceutical Group
- 4.13.1 Harbin Pharmaceutical Group Company Information
- 4.13.2 Harbin Pharmaceutical Group Business Overview
- 4.13.3 Harbin Pharmaceutical Group Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Harbin Pharmaceutical Group Chinese Medicine Injection Product Portfolio
- 4.13.5 Harbin Pharmaceutical Group Recent Developments
- 4.14 Buchang Pharmaceutical
- 4.14.1 Buchang Pharmaceutical Company Information
- 4.14.2 Buchang Pharmaceutical Business Overview
- 4.14.3 Buchang Pharmaceutical Chinese Medicine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Buchang Pharmaceutical Chinese Medicine Injection Product Portfolio
- 4.14.5 Buchang Pharmaceutical Recent Developments
5 Global Chinese Medicine Injection Market Scenario by Region
- 5.1 Global Chinese Medicine Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Chinese Medicine Injection Sales by Region: 2021-2032
- 5.2.1 Global Chinese Medicine Injection Sales by Region: 2021-2026
- 5.2.2 Global Chinese Medicine Injection Sales by Region: 2027-2032
- 5.3 Global Chinese Medicine Injection Revenue by Region: 2021-2032
- 5.3.1 Global Chinese Medicine Injection Revenue by Region: 2021-2026
- 5.3.2 Global Chinese Medicine Injection Revenue by Region: 2027-2032
- 5.4 North America Chinese Medicine Injection Market Facts & Figures by Country
- 5.4.1 North America Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Chinese Medicine Injection Sales by Country (2021-2032)
- 5.4.3 North America Chinese Medicine Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Chinese Medicine Injection Market Facts & Figures by Country
- 5.5.1 Europe Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Chinese Medicine Injection Sales by Country (2021-2032)
- 5.5.3 Europe Chinese Medicine Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Chinese Medicine Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Chinese Medicine Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Chinese Medicine Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Chinese Medicine Injection Market Facts & Figures by Country
- 5.7.1 South America Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Chinese Medicine Injection Sales by Country (2021-2032)
- 5.7.3 South America Chinese Medicine Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Chinese Medicine Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Chinese Medicine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Chinese Medicine Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Chinese Medicine Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Chinese Medicine Injection Sales by Type (2021-2032)
- 6.1.1 Global Chinese Medicine Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Chinese Medicine Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Chinese Medicine Injection Revenue by Type (2021-2032)
- 6.2.1 Global Chinese Medicine Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Chinese Medicine Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Chinese Medicine Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Chinese Medicine Injection Sales by Application (2021-2032)
- 7.1.1 Global Chinese Medicine Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Chinese Medicine Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Chinese Medicine Injection Revenue by Application (2021-2032)
- 7.2.1 Global Chinese Medicine Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Chinese Medicine Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Chinese Medicine Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Chinese Medicine Injection Value Chain Analysis
- 8.1.1 Chinese Medicine Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Chinese Medicine Injection Production Mode & Process
- 8.2 Chinese Medicine Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Chinese Medicine Injection Distributors
- 8.2.3 Chinese Medicine Injection Customers
9 Global Chinese Medicine Injection Analyzing Market Dynamics
- 9.1 Chinese Medicine Injection Industry Trends
- 9.2 Chinese Medicine Injection Industry Drivers
- 9.3 Chinese Medicine Injection Industry Opportunities and Challenges
- 9.4 Chinese Medicine Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst